nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—CMA1—tunica intima—polycystic ovary syndrome	0.105	0.235	CbGeAlD
Boceprevir—CTSL—embryo—polycystic ovary syndrome	0.0142	0.0319	CbGeAlD
Boceprevir—CTSV—endometrium—polycystic ovary syndrome	0.0127	0.0286	CbGeAlD
Boceprevir—CTSL—adrenal cortex—polycystic ovary syndrome	0.0117	0.0262	CbGeAlD
Boceprevir—CTSV—pituitary gland—polycystic ovary syndrome	0.0115	0.0259	CbGeAlD
Boceprevir—CTSV—adipose tissue—polycystic ovary syndrome	0.0115	0.0258	CbGeAlD
Boceprevir—CMA1—adipose tissue—polycystic ovary syndrome	0.011	0.0246	CbGeAlD
Boceprevir—CTSL—endometrium—polycystic ovary syndrome	0.0104	0.0234	CbGeAlD
Boceprevir—CMA1—adrenal gland—polycystic ovary syndrome	0.00984	0.0221	CbGeAlD
Boceprevir—CTSV—female gonad—polycystic ovary syndrome	0.00961	0.0216	CbGeAlD
Boceprevir—CTSL—uterus—polycystic ovary syndrome	0.00959	0.0215	CbGeAlD
Boceprevir—CTSV—vagina—polycystic ovary syndrome	0.00955	0.0214	CbGeAlD
Boceprevir—CTSL—pituitary gland—polycystic ovary syndrome	0.00942	0.0211	CbGeAlD
Boceprevir—CTSS—embryo—polycystic ovary syndrome	0.00939	0.0211	CbGeAlD
Boceprevir—CTSL—adipose tissue—polycystic ovary syndrome	0.00938	0.0211	CbGeAlD
Boceprevir—Sinus congestion—Metformin—polycystic ovary syndrome	0.00899	0.0595	CcSEcCtD
Boceprevir—CTSV—endocrine gland—polycystic ovary syndrome	0.00893	0.0201	CbGeAlD
Boceprevir—CTSK—adrenal cortex—polycystic ovary syndrome	0.00878	0.0197	CbGeAlD
Boceprevir—CMA1—endocrine gland—polycystic ovary syndrome	0.00853	0.0192	CbGeAlD
Boceprevir—CTSL—adrenal gland—polycystic ovary syndrome	0.00841	0.0189	CbGeAlD
Boceprevir—CTSL—female gonad—polycystic ovary syndrome	0.00785	0.0176	CbGeAlD
Boceprevir—CTSK—endometrium—polycystic ovary syndrome	0.00784	0.0176	CbGeAlD
Boceprevir—CTSL—vagina—polycystic ovary syndrome	0.0078	0.0175	CbGeAlD
Boceprevir—CTSS—adrenal cortex—polycystic ovary syndrome	0.0077	0.0173	CbGeAlD
Boceprevir—CTSL—endocrine gland—polycystic ovary syndrome	0.0073	0.0164	CbGeAlD
Boceprevir—CYP3A4—urine—polycystic ovary syndrome	0.00724	0.0163	CbGeAlD
Boceprevir—CTSK—uterus—polycystic ovary syndrome	0.00723	0.0162	CbGeAlD
Boceprevir—CTSK—pituitary gland—polycystic ovary syndrome	0.0071	0.0159	CbGeAlD
Boceprevir—CTSK—adipose tissue—polycystic ovary syndrome	0.00707	0.0159	CbGeAlD
Boceprevir—CTSS—endometrium—polycystic ovary syndrome	0.00687	0.0154	CbGeAlD
Boceprevir—CTSK—adrenal gland—polycystic ovary syndrome	0.00634	0.0142	CbGeAlD
Boceprevir—CTSS—uterus—polycystic ovary syndrome	0.00633	0.0142	CbGeAlD
Boceprevir—CTSS—pituitary gland—polycystic ovary syndrome	0.00622	0.014	CbGeAlD
Boceprevir—CTSS—adipose tissue—polycystic ovary syndrome	0.00619	0.0139	CbGeAlD
Boceprevir—CTSK—female gonad—polycystic ovary syndrome	0.00591	0.0133	CbGeAlD
Boceprevir—CTSK—vagina—polycystic ovary syndrome	0.00588	0.0132	CbGeAlD
Boceprevir—CTSS—adrenal gland—polycystic ovary syndrome	0.00555	0.0125	CbGeAlD
Boceprevir—CTSK—endocrine gland—polycystic ovary syndrome	0.0055	0.0123	CbGeAlD
Boceprevir—CTSS—female gonad—polycystic ovary syndrome	0.00518	0.0116	CbGeAlD
Boceprevir—CTSS—vagina—polycystic ovary syndrome	0.00515	0.0116	CbGeAlD
Boceprevir—Chest discomfort—Metformin—polycystic ovary syndrome	0.00506	0.0334	CcSEcCtD
Boceprevir—CTSS—endocrine gland—polycystic ovary syndrome	0.00482	0.0108	CbGeAlD
Boceprevir—Nasal congestion—Metformin—polycystic ovary syndrome	0.00357	0.0236	CcSEcCtD
Boceprevir—Lethargy—Metformin—polycystic ovary syndrome	0.00331	0.0219	CcSEcCtD
Boceprevir—Pain in extremity—Metformin—polycystic ovary syndrome	0.00325	0.0215	CcSEcCtD
Boceprevir—Migraine—Metformin—polycystic ovary syndrome	0.0032	0.0211	CcSEcCtD
Boceprevir—Dehydration—Metformin—polycystic ovary syndrome	0.00302	0.02	CcSEcCtD
Boceprevir—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00297	0.0196	CcSEcCtD
Boceprevir—Breast disorder—Metformin—polycystic ovary syndrome	0.00294	0.0194	CcSEcCtD
Boceprevir—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.0029	0.0192	CcSEcCtD
Boceprevir—Abdominal distension—Metformin—polycystic ovary syndrome	0.00283	0.0187	CcSEcCtD
Boceprevir—Influenza—Metformin—polycystic ovary syndrome	0.00281	0.0186	CcSEcCtD
Boceprevir—Pancreatitis—Metformin—polycystic ovary syndrome	0.00275	0.0182	CcSEcCtD
Boceprevir—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00269	0.0178	CcSEcCtD
Boceprevir—Neutropenia—Metformin—polycystic ovary syndrome	0.00263	0.0174	CcSEcCtD
Boceprevir—Infestation NOS—Metformin—polycystic ovary syndrome	0.0025	0.0165	CcSEcCtD
Boceprevir—Infestation—Metformin—polycystic ovary syndrome	0.0025	0.0165	CcSEcCtD
Boceprevir—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00245	0.0162	CcSEcCtD
Boceprevir—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00237	0.0157	CcSEcCtD
Boceprevir—Rhinitis—Metformin—polycystic ovary syndrome	0.00225	0.0149	CcSEcCtD
Boceprevir—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00224	0.0148	CcSEcCtD
Boceprevir—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00221	0.0146	CcSEcCtD
Boceprevir—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00221	0.0146	CcSEcCtD
Boceprevir—Eye disorder—Metformin—polycystic ovary syndrome	0.0021	0.0139	CcSEcCtD
Boceprevir—Flushing—Metformin—polycystic ovary syndrome	0.00209	0.0138	CcSEcCtD
Boceprevir—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00209	0.0138	CcSEcCtD
Boceprevir—CYP3A5—adipose tissue—polycystic ovary syndrome	0.00206	0.00462	CbGeAlD
Boceprevir—Angiopathy—Metformin—polycystic ovary syndrome	0.00204	0.0135	CcSEcCtD
Boceprevir—Immune system disorder—Metformin—polycystic ovary syndrome	0.00203	0.0134	CcSEcCtD
Boceprevir—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00203	0.0134	CcSEcCtD
Boceprevir—Chills—Metformin—polycystic ovary syndrome	0.00202	0.0133	CcSEcCtD
Boceprevir—Malnutrition—Metformin—polycystic ovary syndrome	0.00196	0.0129	CcSEcCtD
Boceprevir—Erythema—Metformin—polycystic ovary syndrome	0.00196	0.0129	CcSEcCtD
Boceprevir—Flatulence—Metformin—polycystic ovary syndrome	0.00193	0.0127	CcSEcCtD
Boceprevir—Dysgeusia—Metformin—polycystic ovary syndrome	0.00192	0.0127	CcSEcCtD
Boceprevir—Muscle spasms—Metformin—polycystic ovary syndrome	0.00188	0.0124	CcSEcCtD
Boceprevir—Vision blurred—Metformin—polycystic ovary syndrome	0.00184	0.0122	CcSEcCtD
Boceprevir—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00181	0.012	CcSEcCtD
Boceprevir—Malaise—Metformin—polycystic ovary syndrome	0.00176	0.0117	CcSEcCtD
Boceprevir—Syncope—Metformin—polycystic ovary syndrome	0.00175	0.0116	CcSEcCtD
Boceprevir—Palpitations—Metformin—polycystic ovary syndrome	0.00173	0.0114	CcSEcCtD
Boceprevir—CYP3A5—female gonad—polycystic ovary syndrome	0.00172	0.00386	CbGeAlD
Boceprevir—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00172	0.0114	CcSEcCtD
Boceprevir—CYP3A5—vagina—polycystic ovary syndrome	0.00171	0.00384	CbGeAlD
Boceprevir—Hypertension—Metformin—polycystic ovary syndrome	0.00169	0.0112	CcSEcCtD
Boceprevir—Myalgia—Metformin—polycystic ovary syndrome	0.00167	0.011	CcSEcCtD
Boceprevir—Chest pain—Metformin—polycystic ovary syndrome	0.00167	0.011	CcSEcCtD
Boceprevir—ABCB1—embryo—polycystic ovary syndrome	0.00166	0.00372	CbGeAlD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00165	0.0109	CcSEcCtD
Boceprevir—Discomfort—Metformin—polycystic ovary syndrome	0.00165	0.0109	CcSEcCtD
Boceprevir—CYP3A5—endocrine gland—polycystic ovary syndrome	0.0016	0.00359	CbGeAlD
Boceprevir—Infection—Metformin—polycystic ovary syndrome	0.00159	0.0105	CcSEcCtD
Boceprevir—Shock—Metformin—polycystic ovary syndrome	0.00157	0.0104	CcSEcCtD
Boceprevir—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00157	0.0104	CcSEcCtD
Boceprevir—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00156	0.0103	CcSEcCtD
Boceprevir—Skin disorder—Metformin—polycystic ovary syndrome	0.00155	0.0103	CcSEcCtD
Boceprevir—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00154	0.0102	CcSEcCtD
Boceprevir—Hypotension—Metformin—polycystic ovary syndrome	0.00149	0.00986	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00145	0.00962	CcSEcCtD
Boceprevir—Paraesthesia—Metformin—polycystic ovary syndrome	0.00143	0.00948	CcSEcCtD
Boceprevir—Dyspnoea—Metformin—polycystic ovary syndrome	0.00142	0.00941	CcSEcCtD
Boceprevir—Dyspepsia—Metformin—polycystic ovary syndrome	0.00141	0.00929	CcSEcCtD
Boceprevir—Decreased appetite—Metformin—polycystic ovary syndrome	0.00139	0.00917	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00138	0.00911	CcSEcCtD
Boceprevir—Fatigue—Metformin—polycystic ovary syndrome	0.00138	0.0091	CcSEcCtD
Boceprevir—Constipation—Metformin—polycystic ovary syndrome	0.00137	0.00903	CcSEcCtD
Boceprevir—ABCB1—adrenal cortex—polycystic ovary syndrome	0.00136	0.00305	CbGeAlD
Boceprevir—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00132	0.0087	CcSEcCtD
Boceprevir—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00131	0.00863	CcSEcCtD
Boceprevir—Urticaria—Metformin—polycystic ovary syndrome	0.00127	0.00838	CcSEcCtD
Boceprevir—Abdominal pain—Metformin—polycystic ovary syndrome	0.00126	0.00834	CcSEcCtD
Boceprevir—ABCB1—endometrium—polycystic ovary syndrome	0.00121	0.00272	CbGeAlD
Boceprevir—CYP3A4—endocrine gland—polycystic ovary syndrome	0.0012	0.0027	CbGeAlD
Boceprevir—Asthenia—Metformin—polycystic ovary syndrome	0.00115	0.00757	CcSEcCtD
Boceprevir—Pruritus—Metformin—polycystic ovary syndrome	0.00113	0.00747	CcSEcCtD
Boceprevir—ABCB1—uterus—polycystic ovary syndrome	0.00112	0.00251	CbGeAlD
Boceprevir—ABCB1—pituitary gland—polycystic ovary syndrome	0.0011	0.00246	CbGeAlD
Boceprevir—ABCB1—adipose tissue—polycystic ovary syndrome	0.00109	0.00245	CbGeAlD
Boceprevir—Diarrhoea—Metformin—polycystic ovary syndrome	0.00109	0.00722	CcSEcCtD
Boceprevir—Dizziness—Metformin—polycystic ovary syndrome	0.00106	0.00698	CcSEcCtD
Boceprevir—Vomiting—Metformin—polycystic ovary syndrome	0.00102	0.00671	CcSEcCtD
Boceprevir—Rash—Metformin—polycystic ovary syndrome	0.00101	0.00665	CcSEcCtD
Boceprevir—Dermatitis—Metformin—polycystic ovary syndrome	0.00101	0.00665	CcSEcCtD
Boceprevir—Headache—Metformin—polycystic ovary syndrome	0.001	0.00661	CcSEcCtD
Boceprevir—ABCB1—adrenal gland—polycystic ovary syndrome	0.00098	0.0022	CbGeAlD
Boceprevir—Nausea—Metformin—polycystic ovary syndrome	0.000948	0.00627	CcSEcCtD
Boceprevir—ABCB1—female gonad—polycystic ovary syndrome	0.000914	0.00205	CbGeAlD
Boceprevir—ABCB1—vagina—polycystic ovary syndrome	0.000908	0.00204	CbGeAlD
Boceprevir—ABCB1—endocrine gland—polycystic ovary syndrome	0.00085	0.00191	CbGeAlD
Boceprevir—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000349	0.000865	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—LEP—polycystic ovary syndrome	0.000349	0.000864	CbGpPWpGaD
Boceprevir—CTSS—Immune System—GAB1—polycystic ovary syndrome	0.000345	0.000854	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—AKT2—polycystic ovary syndrome	0.00034	0.000844	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—AKT2—polycystic ovary syndrome	0.00034	0.000844	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000338	0.000839	CbGpPWpGaD
Boceprevir—CTSS—Toll-Like Receptors Cascades—IL6—polycystic ovary syndrome	0.000338	0.000837	CbGpPWpGaD
Boceprevir—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000336	0.000833	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—NRG1—polycystic ovary syndrome	0.000336	0.000832	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000332	0.000824	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000331	0.000821	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.00033	0.000817	CbGpPWpGaD
Boceprevir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000329	0.000815	CbGpPWpGaD
Boceprevir—CTSK—Immune System—ATF1—polycystic ovary syndrome	0.000329	0.000814	CbGpPWpGaD
Boceprevir—CYP3A5—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000327	0.000812	CbGpPWpGaD
Boceprevir—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000324	0.000804	CbGpPWpGaD
Boceprevir—CYP3A5—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000323	0.0008	CbGpPWpGaD
Boceprevir—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000322	0.000797	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—IRS1—polycystic ovary syndrome	0.000317	0.000787	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CAMK2D—polycystic ovary syndrome	0.000313	0.000776	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—BCL2—polycystic ovary syndrome	0.00031	0.000768	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—BCL2—polycystic ovary syndrome	0.00031	0.000768	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ABCB6—polycystic ovary syndrome	0.000309	0.000765	CbGpPWpGaD
Boceprevir—CTSS—Immune System—TNRC6B—polycystic ovary syndrome	0.000308	0.000764	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000308	0.000763	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL18—polycystic ovary syndrome	0.000305	0.000756	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL18—polycystic ovary syndrome	0.000305	0.000756	CbGpPWpGaD
Boceprevir—CYP3A5—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000305	0.000756	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—IRS1—polycystic ovary syndrome	0.000305	0.000755	CbGpPWpGaD
Boceprevir—CYP3A5—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000304	0.000754	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000303	0.000752	CbGpPWpGaD
Boceprevir—CTSK—Immune System—TAB1—polycystic ovary syndrome	0.000303	0.000752	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.000302	0.000748	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PRL—polycystic ovary syndrome	0.0003	0.000745	CbGpPWpGaD
Boceprevir—CYP3A5—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.0003	0.000744	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—POMC—polycystic ovary syndrome	0.0003	0.000743	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—CRP—polycystic ovary syndrome	0.000299	0.000742	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—IRS2—polycystic ovary syndrome	0.000299	0.000742	CbGpPWpGaD
Boceprevir—CTSV—Immune System—NRG1—polycystic ovary syndrome	0.000298	0.000739	CbGpPWpGaD
Boceprevir—CTSL—Immune System—NRG1—polycystic ovary syndrome	0.000298	0.000739	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—INS—polycystic ovary syndrome	0.000298	0.000739	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—AKT2—polycystic ovary syndrome	0.000294	0.000728	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—INSR—polycystic ovary syndrome	0.00029	0.000719	CbGpPWpGaD
Boceprevir—CMA1—Metabolism of proteins—IGF1—polycystic ovary syndrome	0.000288	0.000714	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—IRS2—polycystic ovary syndrome	0.000287	0.000713	CbGpPWpGaD
Boceprevir—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000286	0.00071	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—AKT2—polycystic ovary syndrome	0.000282	0.000699	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000276	0.000684	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—LEP—polycystic ovary syndrome	0.000274	0.000678	CbGpPWpGaD
Boceprevir—CYP3A5—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000272	0.000676	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000271	0.000673	CbGpPWpGaD
Boceprevir—CTSS—Immune System—ATF1—polycystic ovary syndrome	0.000271	0.000671	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000269	0.000666	CbGpPWpGaD
Boceprevir—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000266	0.00066	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—IRS1—polycystic ovary syndrome	0.000261	0.000648	CbGpPWpGaD
Boceprevir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.00026	0.000645	CbGpPWpGaD
Boceprevir—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000259	0.000643	CbGpPWpGaD
Boceprevir—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000257	0.000636	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—BCL2—polycystic ovary syndrome	0.000257	0.000636	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IRS2—polycystic ovary syndrome	0.000255	0.000633	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IRS2—polycystic ovary syndrome	0.000255	0.000633	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CRP—polycystic ovary syndrome	0.000255	0.000633	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CRP—polycystic ovary syndrome	0.000255	0.000633	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL18—polycystic ovary syndrome	0.000253	0.000627	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—IRS1—polycystic ovary syndrome	0.000251	0.000622	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.00025	0.000619	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.00025	0.000619	CbGpPWpGaD
Boceprevir—CTSS—Immune System—TAB1—polycystic ovary syndrome	0.00025	0.000619	CbGpPWpGaD
Boceprevir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.00025	0.000619	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PRL—polycystic ovary syndrome	0.000247	0.000613	CbGpPWpGaD
Boceprevir—CTSK—Immune System—NRG1—polycystic ovary syndrome	0.000247	0.000613	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—AKT2—polycystic ovary syndrome	0.000242	0.0006	CbGpPWpGaD
Boceprevir—CYP3A5—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000241	0.000597	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000238	0.000591	CbGpPWpGaD
Boceprevir—CYP3A5—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000238	0.000589	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000232	0.000576	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—AKT2—polycystic ovary syndrome	0.000232	0.000576	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IRS1—polycystic ovary syndrome	0.000223	0.000553	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IRS1—polycystic ovary syndrome	0.000223	0.000553	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—TRPV6—polycystic ovary syndrome	0.00022	0.000545	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.00022	0.000545	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000218	0.00054	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—polycystic ovary syndrome	0.000215	0.000532	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IRS2—polycystic ovary syndrome	0.000212	0.000525	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CRP—polycystic ovary syndrome	0.000212	0.000525	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—BCL2—polycystic ovary syndrome	0.000211	0.000524	CbGpPWpGaD
Boceprevir—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000211	0.000523	CbGpPWpGaD
Boceprevir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00021	0.00052	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.000209	0.000518	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL18—polycystic ovary syndrome	0.000208	0.000516	CbGpPWpGaD
Boceprevir—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000207	0.000513	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000207	0.000513	CbGpPWpGaD
Boceprevir—CTSV—Immune System—AKT2—polycystic ovary syndrome	0.000206	0.000512	CbGpPWpGaD
Boceprevir—CTSL—Immune System—AKT2—polycystic ovary syndrome	0.000206	0.000512	CbGpPWpGaD
Boceprevir—CTSS—Immune System—NRG1—polycystic ovary syndrome	0.000204	0.000505	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000199	0.000493	CbGpPWpGaD
Boceprevir—CYP3A5—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000194	0.000481	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000192	0.000475	CbGpPWpGaD
Boceprevir—CYP3A5—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000191	0.000475	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IRS1—polycystic ovary syndrome	0.000185	0.000458	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000184	0.000456	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000183	0.000453	CbGpPWpGaD
Boceprevir—CTSV—Immune System—BCL2—polycystic ovary syndrome	0.00018	0.000447	CbGpPWpGaD
Boceprevir—CTSL—Immune System—BCL2—polycystic ovary syndrome	0.00018	0.000447	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000179	0.000444	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CRP—polycystic ovary syndrome	0.000174	0.000432	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IRS2—polycystic ovary syndrome	0.000174	0.000432	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000172	0.000426	CbGpPWpGaD
Boceprevir—CTSK—Immune System—AKT2—polycystic ovary syndrome	0.000171	0.000424	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NMNAT3—polycystic ovary syndrome	0.000171	0.000423	CbGpPWpGaD
Boceprevir—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00017	0.000421	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000169	0.00042	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000163	0.000403	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—IL6—polycystic ovary syndrome	0.00016	0.000397	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—IL6—polycystic ovary syndrome	0.00016	0.000397	CbGpPWpGaD
Boceprevir—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000156	0.000387	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SUOX—polycystic ovary syndrome	0.000156	0.000387	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—LPCAT2—polycystic ovary syndrome	0.000156	0.000387	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000154	0.000381	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IRS1—polycystic ovary syndrome	0.000152	0.000377	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000152	0.000377	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—LEP—polycystic ovary syndrome	0.00015	0.000373	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.00015	0.000372	CbGpPWpGaD
Boceprevir—CTSK—Immune System—BCL2—polycystic ovary syndrome	0.000149	0.00037	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—polycystic ovary syndrome	0.000148	0.000366	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ISYNA1—polycystic ovary syndrome	0.000145	0.00036	CbGpPWpGaD
Boceprevir—CYP3A5—Biological oxidations—POMC—polycystic ovary syndrome	0.000145	0.000359	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000142	0.000351	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000141	0.000351	CbGpPWpGaD
Boceprevir—CTSS—Immune System—AKT2—polycystic ovary syndrome	0.000141	0.000349	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.00014	0.000346	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000138	0.000343	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000134	0.000332	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—IL6—polycystic ovary syndrome	0.000133	0.000329	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000129	0.00032	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000129	0.000319	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—INS—polycystic ovary syndrome	0.000128	0.000318	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—VEGFA—polycystic ovary syndrome	0.000128	0.000317	CbGpPWpGaD
Boceprevir—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000127	0.000314	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000124	0.000308	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000124	0.000308	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—TEAD2—polycystic ovary syndrome	0.000123	0.000306	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AKR1C2—polycystic ovary syndrome	0.000123	0.000306	CbGpPWpGaD
Boceprevir—CTSS—Immune System—BCL2—polycystic ovary syndrome	0.000123	0.000305	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000118	0.000292	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000118	0.000292	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	0.000118	0.000292	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000112	0.000278	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.00011	0.000274	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	0.00011	0.000272	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—IL6—polycystic ovary syndrome	0.000109	0.000271	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PNPLA2—polycystic ovary syndrome	0.000103	0.000256	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SRD5A1—polycystic ovary syndrome	9.81e-05	0.000243	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	9.66e-05	0.00024	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—STAR—polycystic ovary syndrome	9.36e-05	0.000232	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL6—polycystic ovary syndrome	9.33e-05	0.000231	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL6—polycystic ovary syndrome	9.33e-05	0.000231	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	9.32e-05	0.000231	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	9.32e-05	0.000231	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	9.02e-05	0.000224	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	8.9e-05	0.000221	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	8.43e-05	0.000209	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HMMR—polycystic ovary syndrome	8.34e-05	0.000207	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	8.3e-05	0.000206	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.11e-05	0.000201	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HSD3B1—polycystic ovary syndrome	7.95e-05	0.000197	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	7.94e-05	0.000197	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	7.81e-05	0.000194	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL6—polycystic ovary syndrome	7.73e-05	0.000192	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	7.72e-05	0.000191	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	7.4e-05	0.000183	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	7.26e-05	0.00018	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	7.26e-05	0.00018	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—LHB—polycystic ovary syndrome	7.25e-05	0.00018	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HSD3B2—polycystic ovary syndrome	7.09e-05	0.000176	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—STAR—polycystic ovary syndrome	7.06e-05	0.000175	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	7.06e-05	0.000175	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AKR1C1—polycystic ovary syndrome	6.87e-05	0.00017	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	6.75e-05	0.000167	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	6.73e-05	0.000167	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL6—polycystic ovary syndrome	6.37e-05	0.000158	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SULT2A1—polycystic ovary syndrome	6.32e-05	0.000157	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	6.31e-05	0.000156	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	6.29e-05	0.000156	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—RRM2—polycystic ovary syndrome	6.12e-05	0.000152	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	6e-05	0.000149	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	5.92e-05	0.000147	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—YAP1—polycystic ovary syndrome	5.9e-05	0.000146	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	5.74e-05	0.000142	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	5.74e-05	0.000142	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	5.67e-05	0.000141	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL6—polycystic ovary syndrome	5.61e-05	0.000139	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	5.6e-05	0.000139	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—LHB—polycystic ovary syndrome	5.47e-05	0.000136	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	5.35e-05	0.000133	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	5.29e-05	0.000131	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	5.2e-05	0.000129	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	5.18e-05	0.000128	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	4.81e-05	0.000119	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	4.77e-05	0.000118	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	4.62e-05	0.000115	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	4.56e-05	0.000113	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—TH—polycystic ovary syndrome	4.5e-05	0.000112	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	4.45e-05	0.00011	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	4.38e-05	0.000109	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	4.35e-05	0.000108	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	4.28e-05	0.000106	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	4.22e-05	0.000105	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	4.12e-05	0.000102	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	3.99e-05	9.89e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	3.93e-05	9.74e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	3.88e-05	9.61e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	3.7e-05	9.17e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	3.68e-05	9.11e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	3.5e-05	8.68e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—TH—polycystic ovary syndrome	3.4e-05	8.42e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	3.37e-05	8.36e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	3.32e-05	8.23e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	3.31e-05	8.19e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	3.3e-05	8.17e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	3.19e-05	7.91e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	3.11e-05	7.7e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	3.09e-05	7.67e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	2.94e-05	7.28e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	2.85e-05	7.05e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	2.77e-05	6.88e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	2.74e-05	6.8e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	2.64e-05	6.55e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	2.64e-05	6.53e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	2.6e-05	6.45e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	2.51e-05	6.22e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	2.5e-05	6.21e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	2.48e-05	6.14e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—INS—polycystic ovary syndrome	2.46e-05	6.1e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	2.46e-05	6.09e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	2.42e-05	6e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	2.34e-05	5.79e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—TH—polycystic ovary syndrome	2.09e-05	5.19e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	2.04e-05	5.05e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	1.91e-05	4.75e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	1.89e-05	4.69e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—POMC—polycystic ovary syndrome	1.87e-05	4.63e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—INS—polycystic ovary syndrome	1.86e-05	4.6e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	1.71e-05	4.24e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	1.63e-05	4.04e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	1.54e-05	3.83e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.44e-05	3.57e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.17e-05	2.89e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.15e-05	2.85e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.14e-05	2.84e-05	CbGpPWpGaD
